PURPOSE OF REVIEW: In this review, we summarize the basic principles governing rare variant interpretation in the heritable cardiac arrhythmia syndromes, focusing on recent advances that have led to disease-specific approaches to the interpretation of positive genetic testing results. RECENT FINDINGS: Elucidation of the genetic substrates underlying heritable cardiac arrhythmia syndromes has unearthed new arrhythmogenic mechanisms and given rise to a number of clinically meaningful genotype-phenotype correlations. As such, genetic testing for these disorders now carries important diagnostic, prognostic, and therapeutic implications. Recent large-scale systematic studies designed to explore the background genetic 'noise' rate associated with these genetic tests have provided important insights and enhanced how positive genetic testing results are interpreted for these potentially lethal, yet highly treatable, cardiovascular disorders. SUMMARY: Clinically available genetic tests for heritable cardiac arrhythmia syndromes allow the identification of potentially at-risk family members and contribute to the risk-stratification and selection of therapeutic interventions in affected individuals. The systematic evaluation of the 'signal-to-noise' ratio associated with these genetic tests has proven critical and essential to assessing the probability that a given variant represents a rare pathogenic mutation or an equally rare, yet innocuous, genetic bystander.
PURPOSE OF REVIEW: In this review, we summarize the basic principles governing rare variant interpretation in the heritable cardiac arrhythmia syndromes, focusing on recent advances that have led to disease-specific approaches to the interpretation of positive genetic testing results. RECENT FINDINGS: Elucidation of the genetic substrates underlying heritable cardiac arrhythmia syndromes has unearthed new arrhythmogenic mechanisms and given rise to a number of clinically meaningful genotype-phenotype correlations. As such, genetic testing for these disorders now carries important diagnostic, prognostic, and therapeutic implications. Recent large-scale systematic studies designed to explore the background genetic 'noise' rate associated with these genetic tests have provided important insights and enhanced how positive genetic testing results are interpreted for these potentially lethal, yet highly treatable, cardiovascular disorders. SUMMARY: Clinically available genetic tests for heritable cardiac arrhythmia syndromes allow the identification of potentially at-risk family members and contribute to the risk-stratification and selection of therapeutic interventions in affected individuals. The systematic evaluation of the 'signal-to-noise' ratio associated with these genetic tests has proven critical and essential to assessing the probability that a given variant represents a rare pathogenic mutation or an equally rare, yet innocuous, genetic bystander.
Authors: I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating Journal: Circulation Date: 2000-09-05 Impact factor: 29.690
Authors: A J Moss; W Zareba; W J Hall; P J Schwartz; R S Crampton; J Benhorin; G M Vincent; E H Locati; S G Priori; C Napolitano; A Medina; L Zhang; J L Robinson; K Timothy; J A Towbin; M L Andrews Journal: Circulation Date: 2000-02-15 Impact factor: 29.690
Authors: S G Priori; C Napolitano; M Gasparini; C Pappone; P Della Bella; M Brignole; U Giordano; T Giovannini; C Menozzi; R Bloise; L Crotti; L Terreni; P J Schwartz Journal: Circulation Date: 2000-11-14 Impact factor: 29.690
Authors: Christian van der Werf; Ineke Nederend; Nynke Hofman; Nan van Geloven; Corné Ebink; Ingrid M E Frohn-Mulder; A Marco W Alings; Hans A Bosker; Frank A Bracke; Freek van den Heuvel; Reinier A Waalewijn; Hennie Bikker; J Peter van Tintelen; Zahurul A Bhuiyan; Maarten P van den Berg; Arthur A M Wilde Journal: Circ Arrhythm Electrophysiol Date: 2012-07-10
Authors: Lia Crotti; Cherisse A Marcou; David J Tester; Silvia Castelletti; John R Giudicessi; Margherita Torchio; Argelia Medeiros-Domingo; Savastano Simone; Melissa L Will; Federica Dagradi; Peter J Schwartz; Michael J Ackerman Journal: J Am Coll Cardiol Date: 2012-07-25 Impact factor: 24.094
Authors: Jonathan M Cordeiro; Mark Marieb; Ryan Pfeiffer; Kirstine Calloe; Elena Burashnikov; Charles Antzelevitch Journal: J Mol Cell Cardiol Date: 2009-05 Impact factor: 5.000
Authors: Carey-Anne Eddy; Judith M MacCormick; Seo-Kyung Chung; Jackie R Crawford; Donald R Love; Mark I Rees; Jonathan R Skinner; Andrew N Shelling Journal: Heart Rhythm Date: 2008-06-04 Impact factor: 6.343
Authors: John R Giudicessi; Jamie D Kapplinger; David J Tester; Marielle Alders; Benjamin A Salisbury; Arthur A M Wilde; Michael J Ackerman Journal: Circ Cardiovasc Genet Date: 2012-09-04
Authors: Priyanka Garg; Angelos Oikonomopoulos; Haodong Chen; Yingxin Li; Chi Keung Lam; Karim Sallam; Marco Perez; Robert L Lux; Michael C Sanguinetti; Joseph C Wu Journal: J Am Coll Cardiol Date: 2018-07-03 Impact factor: 24.094
Authors: Bian Li; Jeffrey L Mendenhall; Brett M Kroncke; Keenan C Taylor; Hui Huang; Derek K Smith; Carlos G Vanoye; Jeffrey D Blume; Alfred L George; Charles R Sanders; Jens Meiler Journal: Circ Cardiovasc Genet Date: 2017-10
Authors: Elijah R Behr; Eleonora Savio-Galimberti; Julien Barc; Anders G Holst; Evmorfia Petropoulou; Bram P Prins; Javad Jabbari; Margherita Torchio; Myriam Berthet; Yuka Mizusawa; Tao Yang; Eline A Nannenberg; Federica Dagradi; Peter Weeke; Rachel Bastiaenan; Michael J Ackerman; Stig Haunso; Antoine Leenhardt; Stefan Kääb; Vincent Probst; Richard Redon; Sanjay Sharma; Arthur Wilde; Jacob Tfelt-Hansen; Peter Schwartz; Dan M Roden; Connie R Bezzina; Morten Olesen; Dawood Darbar; Pascale Guicheney; Lia Crotti; Yalda Jamshidi Journal: Cardiovasc Res Date: 2015-02-17 Impact factor: 10.787